30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
Australia Biotechnology & Medical Research

Telix Pharmaceuticals Ltd (TLX)

Track

Over the last 90 days, Telix Pharmaceuticals Ltd. has seen two insider buy transactions totaling $996,738.45. Notably, MD & Group CEO Christian Behrenbruch made two separate purchases in late April 2026. No insider sell transactions were recorded during this period. The stock has experienced an 11.8% price increase over the past 90 days.
Top insiders
Trades
Behrenbruch Christian
MD & Group CEO
1 purchase — total 497,178 USD
Buy 29 Apr 2026
Value US$740,893.06 | Price 424.64 | Shares 95,325
Buy 28 Apr 2026
Value US$2,781,840.83 | Price 225.02 | Shares 17,232
Buy 18 Jan 2024
Value A$2,132,289.00 | Price 13.91 | Shares 153,298
Buy 30 May 2023
Value A$356,738.94 | Price 2.97 | Shares 120,268
Buy 16 Mar 2023
Value A$343,385.01 | Price 6.69 | Shares 51,305
Buy 12 Dec 2022
Value A$73,255.51 | Price 6.70 | Shares 10,930
Buy 3 Feb 2022
Value A$436,000.00 | Price 1.09 | Shares 400,000
Sale 27 Jan 2022
Value A$15,400,000.00 | Price 7.70 | Shares 2,000,000
Sale 27 Jan 2022
Value A$15,400,000.00 | Price 7.70 | Shares 2,000,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-06 2026-04-29 B Purchase
Behrenbruch Christian

MD & Group CEO

Executive Director
95,325 -26.1%
424.64
US$740,893 		95,325 -26.1% 424.64 US$740,893
2026-05-06 2026-04-28 B Purchase
Behrenbruch Christian

MD & Group CEO

Executive Director
17,232 -48.9%
225.02
US$2,781,841 		17,232 -48.9% 225.02 US$2,781,841
2024-01-22 2024-01-18 B Purchase Dr Christian Behrenbruch Director
1,426
467.76
A$2,333,354 		1,426 467.76 A$2,333,354
2023-06-02 2023-05-30 B Purchase Dr Christian Behrenbruch Director
120,268
2.97
A$356,739 		120,268 2.97 A$356,739
2023-03-17 2023-03-16 B Purchase Tiffany Olson Director
51,305
6.69
A$343,385 		51,305 6.69 A$343,385
2022-12-15 2022-12-12 B Purchase Tiffany Olson Director
10,930
6.70
A$73,256 		10,930 6.70 A$73,256
2022-02-03 2022-02-03 B Purchase Dr Christian Behrenbruch Director
400,000
1.09
A$436,000 		400,000 1.09 A$436,000
2022-01-31 2022-01-27 S Sale Dr Christian Behrenbruch Director
2,000,000
7.70
A$15,400,000 		2,000,000 7.70 A$15,400,000
2022-01-31 2022-01-27 S Sale Dr Andreas Kluge Director
2,000,000
7.70
A$15,400,000 		2,000,000 7.70 A$15,400,000
Explore more

More insider trading research around Telix Pharmaceuticals Ltd

More insider trades in Australia
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Asia-Pacific